BAX and neoplasm: Using immunohistochemical analysis of the tumor sections, we determined that the expression of ABCG2 (drug resistance marker), β-catenin and WNT1 (stemness markers) were all significantly decreased in the combined treatment group while pro-apoptotic marker, Bax was increased (Fig. 6d).